Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome.

Clavarino G, Leroy C, Epaulard O, Raskovalova T, Vilotitch A, Pernollet M, Dumestre-Pérard C, Defendi F, Le Maréchal M, Le Gouellec A, Audoin P, Bosson JL, Poignard P, Roustit M, Jacob MC, Cesbron JY

Open source

DOI
10.3389/fimmu.2022.889813
Published
2022
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2022.889813,
  title = {Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome.},
  author = {Clavarino G and Leroy C and Epaulard O and Raskovalova T and Vilotitch A and Pernollet M and Dumestre-Pérard C and Defendi F and Le Maréchal M and Le Gouellec A and Audoin P and Bosson JL and Poignard P and Roustit M and Jacob MC and Cesbron JY},
  year = {2022},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2022.889813},
  url = {https://doi.org/10.3389/fimmu.2022.889813}
}

RIS

TY  - JOUR
TI  - Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome.
AU  - Clavarino G
AU  - Leroy C
AU  - Epaulard O
AU  - Raskovalova T
AU  - Vilotitch A
AU  - Pernollet M
AU  - Dumestre-Pérard C
AU  - Defendi F
AU  - Le Maréchal M
AU  - Le Gouellec A
AU  - Audoin P
AU  - Bosson JL
AU  - Poignard P
AU  - Roustit M
AU  - Jacob MC
AU  - Cesbron JY
PY  - 2022
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2022.889813
UR  - https://doi.org/10.3389/fimmu.2022.889813
ER  - 

APA

G, C., C, L., O, E., T, R., A, V., M, P., C, D., F, D., M, L. M., A, L. G., P, A., JL, B., P, P., M, R., MC, J., & JY, C. (2022). Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2022.889813

Source records